TRIO Study (Tablets, Rings, and Injectables as Options for women)

Status:Completed
Phase:Other
Principal Investigator(s):
Objective:Seeks to evaluate the acceptability of three multipurpose, prevention technologies (MPTs) as delivery forms for HIV prevention and unintended pregnancy among young women in Kenya. The three MPTs include, tablet, Ring and Injection.
Prevention Option(s):Microbicides, MPTs
Study Design:
Official Code: TRIO Study
Related Publications:
The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention
Trial Sponsors: Bill & Melinda Gates Foundation
Start Date
End Date
November 15, 2014
May 15, 2016
Enrollment:0
Age range: 18 Years ↔ 30 Years
Population:Cisgender Women